{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:38:15Z","timestamp":1777091895391,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10517-025-06480-1","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:43Z","timestamp":1758772123000},"page":"312-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antiparkinsonian Activity of Benzenesulfonamide Derivatives, Selective MAO-B Inhibitors"],"prefix":"10.1007","volume":"179","author":[{"given":"A. L.","family":"Khokhlov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. N.","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Shetnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Korsakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S.","family":"Petukhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. P.","family":"Vdovichenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Khokhlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Sh.","family":"Suleimanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"1","key":"6480_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med. 2020;36(1):1-12. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clin Geriatr Med."},{"key":"6480_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphar.2020.00356","volume":"11","author":"M G\u00f3mez-Benito","year":"2020","unstructured":"G\u00f3mez-Benito M, Granado N, Garc\u00eda-Sanz P, et al. Modeling Parkinson\u2019s disease with the alpha-synuclein protein. Front Pharmacol. 2020;11:356. https:\/\/doi.org\/10.3389\/fphar.2020.00356","journal-title":"Front Pharmacol."},{"issue":"3","key":"6480_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1871527321666211231100255","volume":"22","author":"ZX Chew","year":"2023","unstructured":"Chew ZX, Lim CL, Ng KY, et al. The role of monoamine oxidase B inhibitors in the treatment of Parkinson\u2019s disease \u2013 an update. CNS Neurol Disord Drug Targets. 2023; 22(3):329-52. https:\/\/doi.org\/10.2174\/1871527321666211231100255","journal-title":"CNS Neurol Disord Drug Targets."},{"issue":"3","key":"6480_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM. Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci. 2023;10(3):200-31. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci."},{"issue":"6","key":"6480_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548-60. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA."},{"key":"6480_CR6","unstructured":"Aminoff MJ. Pharmacologic management of parkinsonism and other movement disorders. Katzung\u2019s Basic & Clinical Pharmacology. Vanderah TW, ed. McGraw Hill, 2024. P. 517-36."},{"issue":"5\u20136","key":"6480_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00702-022-02465-w","volume":"129","author":"WH Jost","year":"2022","unstructured":"Jost WH. A critical appraisal of MAO-B inhibitors in the treatment of Parkinson\u2019s disease. J Neural Transm (Vienna). 2022;129(5-6):723-36. https:\/\/doi.org\/10.1007\/s00702-022-02465-w","journal-title":"J Neural Transm (Vienna)."},{"key":"6480_CR8","unstructured":"Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. Russian."},{"issue":"21","key":"6480_CR9","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.3390\/molecules26216640","volume":"26","author":"D Osmaniye","year":"2021","unstructured":"Osmaniye D, Kurban B, Sa\u011fl\u0131k BN, et al. Novel thiosemicarbazone derivatives: in vitro and in silico evaluation as potential MAO-B inhibitors. Molecules. 2021;26(21):6640. https:\/\/doi.org\/10.3390\/molecules26216640","journal-title":"Molecules."},{"issue":"2","key":"6480_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","volume":"132","author":"MB Youdim","year":"2001","unstructured":"Youdim MB, Gross A, Finberg JP. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br J Pharmacol. 2001;132(2):500-6. https:\/\/doi.org\/10.1038\/sj.bjp.0703826","journal-title":"Br J Pharmacol."},{"issue":"8","key":"6480_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2174\/1570180820666230321090227","volume":"21","author":"A Petzer","year":"2024","unstructured":"Petzer A, Shetnev A, Efimova J, et al. Pyridazinonesubstituted benzenesulfonamides demonstrate inhibition of monoamine oxidase. Letters Drug Design Discov. 2024;21(8):1429-36. https:\/\/doi.org\/10.2174\/1570180820666230321090227","journal-title":"Letters Drug Design Discov."},{"key":"6480_CR12","doi-asserted-by":"publisher","unstructured":"Shetnev AA, Efimova JA, Gasilina OA, et al. Investigation of novel thiazole derivatives bearing the benzenesulfonamide moiety as MAO inhibitors with a promising activity profiles. Preprints. 2023;2023111294. https:\/\/doi.org\/10.20944\/preprints202311.1294.v1","DOI":"10.20944\/preprints202311.1294.v1"}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06480-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06480-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06480-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:17:42Z","timestamp":1759763862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06480-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6480"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06480-1","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}